Life Sciences Regulatory Policy & Strategy Services
Elexes helps life sciences organizations build clear regulatory policies, submission strategies, and compliance roadmaps that support faster market access and stronger audit readiness. From FDA and EU MDR planning to Health Canada, TGA, and global pathway decisions, our consultants turn complex requirements into practical, defensible action plans for manufacturers, diagnostics teams, and digital health innovators.
Our Regulatory Policy & Strategy Services
Strategic regulatory support for planning, submissions, market entry, and ongoing compliance across major global life sciences frameworks.
Global Strategy
Develop market-specific regulatory strategies for FDA, EU MDR, TGA, Health Canada, and other jurisdictions, helping teams choose the right pathway, sequence submissions, and reduce avoidable delays.
Pre-Submission Support
Prepare for regulatory engagement with pathway analysis, mock meetings, submission planning, and documentation reviews that strengthen your position before formal authority interaction begins.
Readiness Assessment
Assess whether your device, evidence, and quality documentation are truly ready for review, with prioritized gap findings and a practical remediation roadmap.
Agency Responses
Respond to FDA, TGA, Health Canada, and other authority questions with structured, defensible submissions that address deficiencies and keep programs moving forward.
Compliance Assessment
Benchmark current documentation, risk files, clinical evidence, and QMS elements against applicable regulations to identify policy, process, and submission gaps early.
Change Assessments
Evaluate design, labeling, software, manufacturing, or intended-use changes to determine regulatory impact and required actions across authorized markets.
Our Regulatory Strategy Process
Assess Product and Market Goals
We start by reviewing your device, intended use, target markets, evidence base, and business timelines to define the regulatory questions that matter most before resources are committed.
Map Applicable Regulatory Pathways
Our consultants identify the most suitable pathways across FDA, EU MDR, Health Canada, TGA, and other jurisdictions, clarifying classification, submission type, and likely authority expectations.
Evaluate Readiness and Gaps
We examine technical documentation, clinical evidence, risk management, labeling, and QMS alignment to pinpoint weaknesses that could trigger deficiencies, delays, or avoidable rework.
Build the Strategic Roadmap
You receive a prioritized action plan covering remediation steps, submission sequencing, documentation needs, and authority engagement strategy so internal teams can execute with confidence.
Support Execution and Responses
As your program advances, we help refine submissions, prepare pre-sub interactions, and respond to regulator questions with clear, defensible documentation and ongoing RAQA guidance.
Trusted By Innovators
Success Stories
Supporting medical device and diagnostics teams with structured regulatory strategy and measurable compliance outcomes.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
The Elexes Difference
Why Choose Elexes?
Elexes combines strategic regulatory insight with hands-on execution support for complex life sciences programs.
Deep Expertise
50+ years of collective experience across FDA, EU MDR, TGA, Health Canada, and ISO frameworks.
Proven Results
250+ successful projects and 200+ product types supported across diverse medical device categories.
End-to-End Support
From regulatory strategy through approvals and post-market governance, teams get continuity across the full lifecycle.
Flexible Delivery
Project-based, part-time, or embedded RAQA support helps clients scale expertise without adding headcount.
Meet The Elexes Team
Experienced specialists guiding complex regulatory decisions worldwide.
Elexes is a trusted medical device regulatory consulting partner serving life sciences companies with strategic, practical support across global markets. The company has built its reputation by helping manufacturers, diagnostics teams, and digital health innovators navigate regulatory approvals, due diligence, quality system requirements, and post-market obligations with greater clarity and control. Backed by 50+ years of collective experience, the Elexes team supports clients across FDA, EU MDR, Health Canada, TGA, and other international frameworks. Its approach combines regulatory depth with operational discipline, giving clients more than advice alone: they gain structured roadmaps, defensible documentation, and an experienced partner focused on reducing rework, accelerating approvals, and sustaining compliance long after market entry.
250+ ProjectsSuccessful regulatory and compliance engagements completed200+ Product TypesExperience across diverse device and diagnostics categories90% Audit ClearanceStrong inspection and audit readiness outcomes
Frequently Asked Questions
What are regulatory policies in healthcare?
Regulatory policies in healthcare are the rules, guidance frameworks, and internal governance procedures that help organizations meet legal and safety requirements. They cover areas such as product classification, clinical evidence, quality systems, labeling, post-market surveillance, complaint handling, and reporting obligations. For life sciences companies, strong regulatory policies create consistency, reduce compliance risk, and support smoother submissions to authorities like FDA, Health Canada, TGA, and EU regulators.
What are some examples of regulatory policy?
Examples include complaint handling procedures, change control policies, document control rules, adverse event reporting processes, clinical evaluation requirements, risk management procedures aligned with ISO 14971, software lifecycle controls under IEC 62304, and quality system policies under ISO 13485. At a strategic level, regulatory policy also includes market-entry frameworks, submission governance, and internal review standards that guide how products are prepared for FDA, EU MDR, IVDR, or other jurisdictional requirements.
What does a regulatory policy and strategy consultant do?
A regulatory policy and strategy consultant helps life sciences companies determine the right approval pathway, identify applicable regulations, assess documentation readiness, and build a practical roadmap for submissions and ongoing compliance. This often includes classification analysis, gap assessments, pre-submission planning, authority response support, and alignment of quality, clinical, and technical documentation so the overall regulatory position is coherent and defensible.
When should a company engage regulatory strategy support?
The best time is early, ideally during product development or before major market-entry decisions are made. Early strategy support helps define the correct pathway, evidence expectations, testing plans, and documentation structure before costly mistakes are built into the program. It is also valuable before FDA 510(k), PMA, EU MDR, IVDR, TGA, or Health Canada submissions, after deficiency letters, or when significant product changes may affect existing approvals.
How does submission readiness assessment help reduce delays?
A submission readiness assessment identifies weaknesses before regulators do. It reviews technical documentation, clinical evidence, risk management, labeling, and QMS alignment against the actual requirements of the target submission. Instead of discovering gaps through deficiency letters or additional information requests, your team receives a prioritized action plan in advance. That reduces rework, improves submission quality, and helps avoid negative review history that can complicate future interactions.
Can Elexes support global regulatory strategy across multiple markets?
Yes. Elexes supports regulatory strategy across major markets including the USA, Canada, Europe, Australia, the UK, and other international regions. This includes pathway planning for FDA, EU MDR, IVDR, TGA, and Health Canada requirements, along with submission sequencing and documentation alignment. For companies managing multi-market launches, this kind of coordinated strategy helps reduce duplicated effort and keeps evidence packages more consistent across jurisdictions.
What industries or product types are supported?
Elexes supports medical device companies, biotech firms, diagnostic companies, digital health developers, SaMD teams, IVD and LDT manufacturers, clinical laboratories, and related life sciences organizations. The company has experience across 200+ product types, which is especially valuable when regulatory strategy must account for device classification, software requirements, clinical evidence expectations, quality system maturity, and post-market obligations across different product categories.
How do outsourced regulatory strategy services benefit internal teams?
Outsourced regulatory strategy services give internal teams access to specialized expertise without the cost of building a full in-house RAQA function. They help organizations move faster on submissions, strengthen documentation quality, and maintain continuity during growth, audits, or staffing gaps. With flexible project-based or embedded support, companies can add senior regulatory judgment, structured execution, and cross-market experience exactly where it is needed most.
Still Need Regulatory Guidance?
Talk with our consultants about your pathway, readiness, or compliance priorities.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise
MDSAP
Multi-market audit readiness support
IEC 62304
Software lifecycle compliance knowledge
